William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Hayward Holdings Announces Pricing of Initial Public Offering
-
Are These The Top Health Care Stocks To Buy In Right Now?
-
AbacusNext Announces Acquisition by Thomas H. Lee Partners
-
CyberArk Software (CYBR) Extends Into New Markets Doubles TAM, William Blair Reiterates Outperform
-
Form 24F-2NT WILLIAM BLAIR FUNDS For: Dec 31
-
William Blair Downgrades Talend SA (TLND) to Market Perform, Following Acquisition
-
Docusign Inc. (DOCU) Thoughts After Dropbox (DBX) Acquisition - William Blair
-
Vocera Prices Offering of $200.0 Million of 0.50% Convertible Senior Notes Due 2026
-
Xenon Pharmaceuticals (XENE) Prices 4.32M Share Common Offering at $18.50/Sh
-
Xenon Pharmaceuticals Announces Pricing of $100.0 Million Public Offering
-
Xenon Pharmaceuticals Announces Pricing of $100.0 Million Public Offering
-
Oxford Lane Capital Corp. Prices Public Offering of $87.0 Million 6.75% Notes Due 2031 and Announces BBB Investment Grade Rating of the Notes by Egan-Jones Ratings Company
-
Form 497 WILLIAM BLAIR FUNDS
-
Xenon Pharmaceuticals (XENE) to Offer Common Stock
-
Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares
-
Xenon Pharmaceuticals Announces Proposed Public Offering of Common Shares
-
Aioi Nissay Dowa Insurance Services USA and PreAct Technologies Partner to Commercialize Advanced Near-Field Sensing for Usage Based Insurance
-
Oxford Lane Capital Corp. Announces Offering of Notes and BBB Investment Grade Rating of the Notes by Egan-Jones Ratings Company
-
Box to Present at William Blair’s 5th Annual Tech Innovators Conference
-
Vocera Communications (VCRA) to Offer $200 Million of Convertible Senior Notes Due 2026
-
Vocera to Offer $200.0 Million of Convertible Senior Notes Due 2026
-
Commvault to Present at the William Blair Tech Innovators Conference
-
Olo Announces Launch of Initial Public Offering
-
Platinum Equity Acquires Healthcare Products Distributor NDC From Court Square Capital Partners
-
Coursera Files Registration Statement for Proposed Initial Public Offering
-
General Electric shares burn bright on recovery bets
-
Ameresco (AMRC) Prices 3.2M Class A Share Common Offering at $44/Sh
-
Ameresco Announces Pricing of Public Offering of Class A Common Stock
-
Ameresco (AMRC) Announces 3.2M Share Proposed Public Offering of Class A Common Stock
-
Ameresco Announces Proposed Public Offering of Class A Common Stock
-
QAD to Participate in William Blair 5th Annual Tech Innovators Conference
-
InnovAge Holding (INNV) IPO Opens 14% Higher
-
InnovAge Holding Corp. (INNV) IPO Prices at $21
-
Hayward Holdings Launches Initial Public Offering
-
InnovAge Announces Pricing of Initial Public Offering
-
InnovAge Announces Pricing of Initial Public Offering
-
thredUP Files Registration Statement for Proposed Initial Public Offering
-
Alignment Healthcare Announces Filing of Registration Statement for Proposed Initial Public Offering
-
11.2 Ventures Brings on New Industry Sector Heads to Create, Build, and Launch AI-Powered Companies in Their Fields
-
Thornburg Grows Institutional Distribution Team
-
Watlow Acquired By Tinicum L.P.
-
AppLovin Files Registration Statement for Proposed Initial Public Offering
-
Procore Files Amended Registration Statement for Proposed Initial Public Offering
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497 WILLIAM BLAIR FUNDS
-
Sapiens to Participate in William Blair 5th Annual Tech Innovators Conference on March 11, 2021
-
EQT Private Equity to sell Dorner to Columbus McKinnon for an Enterprise Value of USD 485m
-
QOMPLX, a Leader in Cloud-Native Risk Analytics, Elects to Become a Public Company Through a Merger with Tailwind Acquisition Corp
-
Form N-CSR WILLIAM BLAIR FUNDS For: Dec 31
-
Adamas Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

